Erectile dysfunction following prostate ablative therapy
ICD-10 N52.37 is a billable code used to indicate a diagnosis of erectile dysfunction following prostate ablative therapy.
Erectile dysfunction (ED) following prostate ablative therapy is a condition that arises as a complication of treatments aimed at managing prostate cancer, such as cryotherapy, laser therapy, or high-intensity focused ultrasound (HIFU). These therapies, while effective in targeting cancerous tissues, can inadvertently damage the surrounding neurovascular structures essential for erectile function. The incidence of ED post-therapy can vary significantly, influenced by factors such as the patient's age, baseline erectile function, and the specific type of ablative therapy employed. Clinically, patients may report difficulties in achieving or maintaining an erection sufficient for sexual intercourse, which can lead to psychological distress and impact overall quality of life. Management of ED in this context may involve pharmacological treatments, vacuum erection devices, or penile implants, and requires a multidisciplinary approach involving urologists, mental health professionals, and sexual health specialists. Accurate coding of this condition is crucial for appropriate treatment planning and reimbursement.
Detailed records of the patient's prostate cancer treatment history, including type of ablative therapy, dates, and any pre-existing erectile dysfunction.
Patients presenting with ED after undergoing prostatectomy or other ablative therapies, requiring assessment and management.
Urologists should ensure thorough documentation of the patient's baseline erectile function and any psychological factors that may contribute to ED.
Assessment of psychological impact of ED on the patient's mental health, including anxiety and depression related to sexual function.
Patients experiencing anxiety or depression following prostate cancer treatment, impacting their sexual health.
Psychiatrists should collaborate with urologists to address both psychological and physiological aspects of ED.
Used for patients with severe ED post-prostate therapy who do not respond to other treatments.
Document the patient's history of ED, previous treatments attempted, and the decision-making process for surgical intervention.
Urologists should ensure that all conservative treatment options have been exhausted before proceeding with surgical options.
The primary cause is damage to the neurovascular structures surrounding the prostate, which are essential for achieving and maintaining an erection. This damage can occur during various ablative therapies aimed at treating prostate cancer.
